We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

109 hedge funds and large institutions have $1.22B invested in GW Pharmaceuticals Plc American Depositary Shares in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

44% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 25

33% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 18

5% more funds holding

Funds holding: 104 → 109 (+5)

24% less capital invested

Capital invested by funds: $1.62B → $1.22B (-$395M)

56% less call options, than puts

Call options by funds: $47.2M | Put options by funds: $106M

Holders
109
Holders Change
+5
Holders Change %
+4.81%
% of All Funds
3.04%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
24
Increased
36
Reduced
25
Closed
18
Calls
$47.2M
Puts
$106M
Net Calls
-$59.3M
Net Calls Change
-$26.6M

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$122M
2
Bank of America
Bank of America
North Carolina
+$36.1M
3
HCM
Hayman Capital Management
Texas
+$23.4M
4
LCP
Lamond Capital Partners
California
+$13.3M
5
JHIU
Janus Henderson Investors US
Colorado
+$10.9M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$29.5M
2
RG
Redmile Group
California
-$17.9M
3
Franklin Resources
Franklin Resources
California
-$12M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$8.09M
5
FCM
Farallon Capital Management
California
-$7.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$6.36M +$1.72M +15,463 +29%
EAM
27
Eventide Asset Management
Massachusetts
$6.28M +$3.62M +32,600 +90%
Asset Management One
28
Asset Management One
Japan
$5.98M -$632K -5,682 -8%
SFM
29
Sphera Funds Management
Israel
$3.94M -$44.5K -400 -0.9%
AAM
30
Advisors Asset Management
Colorado
$3.89M +$1.26M +11,353 +36%
IHM
31
Iguana Healthcare Management
New York
$3.65M -$556K -5,000 -11%
Millennium Management
32
Millennium Management
New York
$2.77M +$805K +7,236 +31%
GTC
33
Ghost Tree Capital
New York
$2.74M -$5M -45,000 -60%
Citadel Advisors
34
Citadel Advisors
Florida
$2.59M +$2.37M +21,270 +300%
Ameriprise
35
Ameriprise
Minnesota
$2.58M -$111K -1,001 -3%
AC
36
Ascend Capital
California
$2.28M +$2.78M +24,960 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$2.08M -$83.6K -752 -3%
ARTA
38
A.R.T. Advisors
New York
$2.03M +$2.47M +22,201 New
NFA
39
Nationwide Fund Advisors
Ohio
$2.01M – – –
CC
40
CQS Cayman
Cayman Islands
$1.6M – – –
MCM
41
Marsico Capital Management
Colorado
$1.47M +$1.79M +16,083 New
Artisan Partners
42
Artisan Partners
Wisconsin
$1.16M – – –
HI
43
HBK Investments
Texas
$1.15M +$1.4M +12,547 New
SPC
44
Sigma Planning Corp
Michigan
$1.14M -$54.3K -488 -4%
US Bancorp
45
US Bancorp
Minnesota
$1.07M +$952K +8,559 +268%
ProShare Advisors
46
ProShare Advisors
Maryland
$1.04M +$213K +1,913 +20%
TAM
47
Tocqueville Asset Management
New York
$1.04M +$122K +1,100 +11%
PAMU
48
Pictet Asset Management (UK)
United Kingdom
$959K -$1.59M -14,300 -58%
Renaissance Technologies
49
Renaissance Technologies
New York
$959K +$1.17M +10,500 New
Citigroup
50
Citigroup
New York
$900K +$516K +4,645 +89%
1
2
3 4 5

GWPH Hedge Fund Activity: Q3 2015 in Review

109 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2015, worth a combined $1.22B — down 24% from $1.62B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new GWPH positions and 18 closed out — a net gain of 6 holders — while 36 added to existing stakes and 25 trimmed.

The largest buyer was OppenheimerFunds, adding an estimated $122M. The largest seller was Federated Hermes, cutting an estimated $29.5M.

  • 109 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2015, up from 104 in Q2 2015.
  • Funds reported $1.22B of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2015, down 24% quarter-over-quarter.
  • 24 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2015 and 18 closed out, a net change of +6 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2015 was OppenheimerFunds, an estimated $122M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2015 was Federated Hermes, an estimated $29.5M sold.

Based on aggregated 13F filings for Q3 2015.